Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 21 (RPL36AP21) is a human processed pseudogene related to the functional RPL36A gene, which encodes a component of the 60S subunit of the ribosome involved in protein synthesis[10]. Like other processed pseudogenes, RPL36AP21 does not code for a functional protein and has no established biological function or disease association[10]. It is classified as a non-coding element and is not considered a therapeutic target. Ribosomal protein L36a pseudogene 21 (RPL36AP21) is a processed pseudogene of the ribosomal protein L36a gene and does not represent a functional protein, receptor, or therapeutic target[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 21 (RPL36AP21).